Injectables Global Market Makes Hikma, Teva, Agila, Others Major Players
This article was originally published in PharmAsia News
Executive Summary
Although expensive to produce, the global market for injectables is valued at $7 billion, enough to attract Jordan's Hikma Pharmaceuticals and Israel's Teva Pharmaceutical Industries.